本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Scpharmaceuticals Inc.

5.45
+0.04000.74%
盘后5.450.00000.00%16:10 EDT
成交量:16.07万
成交额:88.09万
市值:2.88亿
市盈率:-2.89
高:5.56
开:5.43
低:5.41
收:5.41
数据加载中...
2025/06/10

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/14

重要事件披露

Form 8-K - Current report
2025/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/19

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/31

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/30

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report